| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President And CEO | President And CEO | Director
2 companies
Torley Helen is a President And CEO at Halozyme Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 66 sells.
Estimated insider holdings value: $53.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 13, 2026 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 50,000 | $68.68 | $3,433,874.74 | -0.5% | - | - | |
| Apr 6, 2026 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 10,000 | $63.50 | $634,981.60 | -0.6% | - | - | |
| Dec 1, 2025 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 16,569 | $68.92 | $1,141,924.75 | -0.6% | +2.6% | - | |
| Nov 12, 2025 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 60,000 | $69.47 | $4,167,929.57 | -1.0% | +13.6% | - | |
| Oct 3, 2025 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 60,000 | $71.86 | $4,311,745.12 | -0.7% | +1.9% | - | |
| Sep 4, 2025 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 60,000 | $74.08 | $4,444,626.29 | -1.0% | -11.9% | - | |
| Aug 13, 2025 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 60,000 | $63.62 | $3,817,388.61 | -1.3% | +7.7% | - | |
| Jul 10, 2025 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 60,000 | $56.46 | $3,387,517.46 | -1.3% | +13.1% | - | |
| Jun 24, 2025 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 60,000 | $53.09 | $3,185,279.82 | -2.0% | +45.2% | - | |
| Oct 9, 2024 | HALO Halozyme Therapeutics, Inc. | President And CEO | Sale+OE | 20,000 | $53.29 | $1,065,743.18 | -0.6% | +1.0% | +28.5% |